| Authors: |
Al-Sawaf O; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Stumpf J; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Zhang C; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Simon F; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Bosch F; Department of Hematology, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona., Feyzi E; St. Olavs University Hospital, Department of Hematology, Trondheim, Norway., Ghia P; School of Medicine, Università Vita Salute San Raffaele, Milan.; Comprehensive Cancer Center, IRCCS Ospedale San Raffaele, Milan., Gregor M; Cantonal Hospital of Lucerne, Lucerne, Switzerland., Kater AP; Department of Hematology, Cancer Center Amsterdam, Hemato-Oncology Foundation for Adults Netherlands (HOVON), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam., Lindström V; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki., Mattsson M; Uppsala University Hospital, Uppsala, Sweden., Niemann CU; Rigshospitalet, Copenhagen University Hospital, Copenhagen.; Danish Cancer Institute, Copenhagen., Staber PB; Medical University Vienna, Vienna, Austria.; Saarland University Medical School, Saarland, Germany., Tadmor T; Bnai Zion Medical Center, Technion, Haifa, Israel.; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Thornton P; Cancer Clinical Trials and Research Unit, Cancer Trials Ireland, Beaumont Hospital, Dublin., Wendtner CM; Ludwig-Maximilians University (LMU), Medical Clinic III, Munich, Germany., Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Noesslinger T; Hanusch Krankenhaus, Vienna., Bohn JP; Medical University of Innsbruck, Department of Hematology and Oncology, Innsbruck, Austria., da Cunha-Bang C; Rigshospitalet, Copenhagen University Hospital, Copenhagen., Poulsen CB; Zealand University Hospital, Roskilde, Denmark., Ranti J; Turku University Hospital, Turku, Finland., Illmer T; Berufsausüebungsgemeinschaft, Gokos, Dresden, Germany., Schoettker B; Hämatologisch-Onkologische Schwerpunktpraxis, Wuerzburg, Germany., Böttcher S; Clinic III (Hematology, Oncology, and Palliative Medicine), Rostock University Medical Center, Rostock, Germany., Gaska T; Bruederkrankenhaus Paderborn, Paderborn, Germany., Vandenberghe E; Trinity St. James Cancer Institute, Dublin., Clifford R; University Hospital Limerick, Limerick, Ireland., Benjamini O; Chaim Sheba Medical Center, Ramat Gan, Israel., Frustaci AM; ASST Grande Ospedale Metropolitano Niguarda, Milan., Scarfò L; School of Medicine, Università Vita Salute San Raffaele, Milan.; Comprehensive Cancer Center, IRCCS Ospedale San Raffaele, Milan., Sportoletti P; Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy., Schreurs J; Martini Ziekenhuis, Groningen, the Netherlands., Levin MD; Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands., van der Straaten H; Ziekenhuis St Jansdal, Harderwijk, the Netherlands., van der Klift M; Amphia Ziekenhuis, Breda, the Netherlands., Tran H; Akershus University Hospital, Oslo., de la Serna J; Hospital Universitario 12 de Octubre, Madrid., Loscertales J; Hospital Universitario La Princesa, Madrid., Lindblad O; Skane University Hospital, Lund, Sweden., Bergendahl Sandstedt A; University Hospital Linköping, Linköping, Sweden., Goede J; KS Winterthur, Winterthur, Switzerland., Baumann M; HOCH Health Ostschweiz, Kantonsspital St. Gallen, St. Gallen, Switzerland., Fink AM; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Fischer K; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Ritgen M; Universitaetsklinikum Schleswig-Holstein, Medizinische Klinik II, Kiel, Germany., Kreuzer KA; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Schneider C; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Tausch E; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany., Robrecht S; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Eichhorst B; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany. |
